Skip to main content
Year archive

MEMPHASYS LIMITED. — 2023 filings

All 43 regulatory filings released by MEMPHASYS LIMITED. (MEM) in 2023, sourced directly from the official regulator.

43 Filings
2023 Period
2023 filings (43)
Filing Released Lang
Extension of Rights Issue offer close date 1 page 1
Capital/Financing Update
2023-12-26 English
Appendix 3B extension of closing date of offer 54 pages 1.2MB
Capital/Financing Update
2023-12-26 English
App 4G and Corporate Governance Statement 24 pages 636.2KB
Governance Information
2023-12-14 English
s708A cleansing notice 1 page 174.6KB
Capital/Financing Update
2023-12-12 English
Rights Issue Prospectus Offer - despatch of offer 1
Capital/Financing Update
2023-12-12 English
Rights Issue Prospectus offer - letter to shareholders 3 pages 193.9KB
Capital/Financing Update
2023-12-12 English
Application for quotation of securities - MEM 6 pages 27.9KB
Share Issue/Capital Change
2023-12-10 English
Non-Renounceable Issue Entitlement Offer Prospectus 45 pages 1.2MB
Capital/Financing Update
2023-12-04 English
$4.2m raise to pursue commercial opportunities with Felix 3 pages 269.3KB
Capital/Financing Update
2023-12-03 English
Proposed issue of securities - MEM 15 pages 55.7KB
Capital/Financing Update
2023-12-03 English
Trading Halt 2 pages 172.9KB
Capital/Financing Update
2023-11-29 English
Board and executive transition and capital raise 2 pages 225.0KB
Capital/Financing Update
2023-11-29 English
Final Director's Interest Notice AC 2 pages 145.3KB
Director's Dealing
2023-11-29 English
Final Director's Interest Notice AG 2 pages 187.6KB
Director's Dealing
2023-11-29 English
Initial Director's Interest Notice DA 2 pages 187.0KB
Director's Dealing
2023-11-29 English
Results of Meeting 1 page 146.5KB
Declaration of Voting Results & Voting Rights Announcements
2023-11-21 English
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 508.2KB
Interim / Quarterly Report Q1 2024
2023-10-30 English
R&D refund 1 page 177.1KB
Capital/Financing Update
2023-10-24 English
Notice of Annual General Meeting/Proxy Form 14 pages 584.4KB
AGM Information
2023-10-19 English
In-Depth Investor Webinar Presentation 1 page 162.7
Investor Presentation
2023-09-20 English
Investor Presentation Sept 23 45 pages 2.8MB
Investor Presentation
2023-09-17 English
Notification of cessation of securities - MEM 4 pages 23.8KB
Regulatory Filings
2023-09-14 English
Felix System records 10 new live births in India 2 pages 214.8KB
Capital/Financing Update
2023-09-14 English
Preliminary Final Report 78 pages 1.7MB
Annual Report FY 2023
2023-08-29 English
Initial Felix System order placed by Vitrolife Japan 2 pages 215.9KB
Capital/Financing Update
2023-08-13 English
Vitrolife sign Felix distribution agreement for Japanese mkt 2 pages 192.0KB
Capital/Financing Update
2023-08-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 10 pages 476.3KB
Interim / Quarterly Report Q4 2023
2023-07-27 English
New Patents granted for Felix System 1 page 181.1KB
Regulatory Filings
2023-07-12 English
Notification of cessation of securities - MEM 4 pages 24.4KB
Regulatory Filings
2023-06-07 English
Felix considered best method to treat cryopreserved semen 2 pages 233.4KB
Regulatory Filings
2023-06-05 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 355.2KB
Interim / Quarterly Report Q3 2023
2023-04-27 English
Investor presentation April 2023 23 pages 1.5MB
Investor Presentation
2023-04-04 English
Japan first commercial sale and first baby born using Felix 2 pages 170.7KB
Capital/Financing Update
2023-04-02 English
Experienced fertility expert appointed Operations Director 2 pages 170.9KB
Board/Management Information
2023-03-29 English
Highly-credentialled exec appointed as Director of BusDev 1
Board/Management Information
2023-02-27 English
Half Yearly Report and Accounts 26 pages 1.8MB
Interim / Quarterly Report H1 2023
2023-02-23 English
KOL testings demonstrate Felix System outperforms DGC 3 pages 556.2KB
Regulatory Filings
2023-02-06 English
Quarterly Activities/Appendix 4C Cash Flow Report 8 pages 1.8MB
Interim / Quarterly Report Q2 2023
2023-01-30 English
Notification of cessation of securities - MEM 4 pages 24.4KB
Share Issue/Capital Change
2023-01-16 English
Change of Director's Interest Notice correction 3 pages 177.5KB
Director's Dealing
2023-01-11 English
Change of Director's Interest Notice correction 2 pages 182.3KB
Director's Dealing
2023-01-11 English
Change of Director's Interest Notice - AG 2 pages 182.2KB
Director's Dealing
2023-01-02 English
Change of Director's Interest Notice - AC 3 pages 177.4KB
Director's Dealing
2023-01-02 English